APA (7th ed.) Citation

Mirgh, S., Gokarn, A., Punatar, S., Chichra, A., Singh, A., Rajendra, A., . . . Khattry, N. (2021). Clinical course of severe COVID19 treated with tocilizumab and antivirals post‐allogeneic stem cell transplant with extensive chronic GVHD. Transplant Infectious Disease, 23(4), 1. https://doi.org/10.1111/tid.13576

Chicago Style (17th ed.) Citation

Mirgh, Sumeet, et al. "Clinical Course of Severe COVID19 Treated with Tocilizumab and Antivirals Post‐allogeneic Stem Cell Transplant with Extensive Chronic GVHD." Transplant Infectious Disease 23, no. 4 (2021): 1. https://doi.org/10.1111/tid.13576.

MLA (9th ed.) Citation

Mirgh, Sumeet, et al. "Clinical Course of Severe COVID19 Treated with Tocilizumab and Antivirals Post‐allogeneic Stem Cell Transplant with Extensive Chronic GVHD." Transplant Infectious Disease, vol. 23, no. 4, 2021, p. 1, https://doi.org/10.1111/tid.13576.